How did BRTX's revenue and expenses shift in Q4 2024?
5/9/2025 05:12am
Biorestorative Technology (BRTX) experienced a significant increase in total revenue for Q4 2024, reaching $43,300 compared to an undisclosed amount in the previous quarter. However, the total expenses for the same period were not provided, making it difficult to assess the company's financial performance in terms of profitability. The absence of expense data precludes a full analysis of BRTX's financial health for Q4 2024.
|code|Ticker|Name|Date|Total Revenue|market_code|
|---|---|---|---|---|---|
|BRTX|BRTX.O|Biorestorative|2024 Q1|35000|186|
|BRTX|BRTX.O|Biorestorative|2024 Q2|89100|186|
|BRTX|BRTX.O|Biorestorative|2024 Q3|233600|186|
|BRTX|BRTX.O|Biorestorative|2024 Q4|43300|186|